Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Advances in structural and molecular neuroimaging in Alzheimer's disease.

Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O.

Med J Aust. 2011 Feb 21;194(4):S20-3.

PMID:
21401483
2.

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.

Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D; AIBL Research Group.

Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27.

PMID:
19470201
3.

Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.

Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D; AIBL research group.

Alzheimers Dement. 2010 May;6(3):291-6. doi: 10.1016/j.jalz.2010.03.009.

PMID:
20451879
4.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
5.
6.

Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.

Román G, Pascual B.

Arch Med Res. 2012 Nov;43(8):671-6. doi: 10.1016/j.arcmed.2012.10.018. Epub 2012 Nov 8. Review.

PMID:
23142262
7.

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.

Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9.

8.

Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease?

Nichols L, Pike VW, Cai L, Innis RB.

Biol Psychiatry. 2006 May 15;59(10):940-7. Epub 2006 Feb 17. Review.

PMID:
16487944
9.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

10.

Imaging in Alzheimer's disease.

Scheltens P.

Dialogues Clin Neurosci. 2009;11(2):191-9. Review.

11.

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.

Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL.

J Clin Neurosci. 2005 Apr;12(3):221-30. Review.

PMID:
15851069
12.

[Pre-symptomatic detection of Alzheimer's disease and mild cognitive impairment].

Arai H.

Rinsho Shinkeigaku. 2009 Nov;49(11):838-40. Review. Japanese.

PMID:
20030225
13.

Neuroimaging in dementia: in vivo amyloid imaging.

Suhara T, Higuchi M, Miyoshi M.

Tohoku J Exp Med. 2008 Jun;215(2):119-24. Review.

14.

Toward an early diagnosis and treatment of Alzheimer's disease.

Nordberg A.

Int Psychogeriatr. 2003 Sep;15(3):223-37.

PMID:
14756159
15.

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC.

Mol Neurobiol. 2008 Aug;38(1):1-15. doi: 10.1007/s12035-008-8019-y. Epub 2008 Aug 9. Review.

PMID:
18690556
16.

[Alzheimer's and related diseases: toward earlier and more accurate diagnosis].

Fortin MP, Krolak-Salmon P.

Rev Med Interne. 2010 Dec;31(12):846-53. doi: 10.1016/j.revmed.2010.08.006. Epub 2010 Oct 16. French.

PMID:
20952104
17.
18.

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.

Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL.

Neurobiol Aging. 2010 Aug;31(8):1275-83. doi: 10.1016/j.neurobiolaging.2010.04.007. Epub 2010 May 15.

PMID:
20472326
19.

The role of positron emission tomography imaging of beta-amyloid in patients with Alzheimer's disease.

Xiong KL, Yang QW, Gong SG, Zhang WG.

Nucl Med Commun. 2010 Jan;31(1):4-11. Review.

PMID:
19972633
20.

Biomarkers for Alzheimer's disease.

Pauwels EK, Volterrani D, Mariani G.

Drug News Perspect. 2009 Apr;22(3):151-60. doi: 10.1358/dnp.2009.22.3.1354128. Review.

PMID:
19440558
Items per page

Supplemental Content

Write to the Help Desk